Replies to post #2589 on Revance Therapeutics Inc (RVNC)

[DewDiligence]

RVNC fully-diluted shares @7/29/22=92.2M—an increase of 1.3M shares since 3/31/22 (#msg-168853899) derived from the new ATM facility:

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001479290/000147929022000082/rvnc-20220630.htm#i95a959e23a9c4d189948f4c4848a428f_16 (page 47)

The 92.2M figure mentioned above consists of: 73.1M basic shares; 5.0M options; 5.2M shares of unvested restricted stock/RSUs; and 8.9M shares deriving from the convertible debt issued in Feb 2020. (Excluding the shares derived from the convertible debt, fully-diluted shares at 7/29/22 were 83.3M.)